Canary Speech, a maker of AI-enabled speech analysis software, has raised $13 million in Series A funding led by Cortes Capital. The company offers vocal biomarker technology that analyzes speech to detect mood, stress, and energy levels before clinical screenings. They have nine patents related to vocal biomarkers and plan to expand their workforce with the new funding. Canary has partnered with Microsoft to enhance their machine learning speech models for healthcare and has also collaborated with companies like Life365 and Hackensack Meridian Health. The company aims to revolutionize healthcare with its innovative technology alongside competitors like Voiceitt and NVIDIA.
Source link
Canary Speech secures $13M for AI-enabled speech recognition software
